Hinge Health initiated with an Outperform at Raymond James

Raymond James initiated coverage of Hinge Health (HNGE) with an Outperform rating and $45 price target As a leader in providing digital physical therapy and with the strength of its partner network, Hinge Health has “ample room” for sustained double-digit growth, the analyst tells investors in a research note. The firm says that with multiple upside drivers and little contribution from new markets, it does not believe the stock’s current valuation sales appropriately values the company’s growth prospects.